Lucid Diagnostics Inc. Common Stock
$0.9614
USD
Last updated on --.
24h volume826.56K
24h highest1.0300 USD
24h lowest0.96200 USD
24h Price movement-0.60%
LUCD recent prices
24 Hours
-0.60%-$0.0058
30 days
-6.66%-$0.0686
60 days
-14.16%-$0.1586
90 days
-34.15%-$0.4986
Key data
Previous close0.96720 USD
Market cap196.48M USD
Volume826.56K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.30000 USD
Net income (FY)-45.01M USD
Revenue (FY)5.13M USD
Last report dateMay 13, 2026
About Lucid Diagnostics Inc. Common Stock
HeadquartersNEW YORK
Employees (FY)82.00
Revenue per employee (FY)62.61K USD
Net income per employee (FY)-548.91K USD
Listed onNasdaq
LUCD conversion tables
 |  |
|---|---|
| 0.5 LUCD | 0.4807 USD |
| 1 LUCD | 0.9614 USD |
| 5 LUCD | 4.807 USD |
| 10 LUCD | 9.614 USD |
| |
|---|---|
| 0.5 USD | 0.52007 LUCD |
| 1 USD | 1.040 LUCD |
| 5 USD | 5.200 LUCD |
| 10 USD | 10.4 LUCD |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
LUCD is trading at $0.9614, -0.60% over the last 24 hours. Track live moves on the price chart at the top of this page.
The LUCD stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. LUCD is currently trading at $0.9614, -0.60% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on LUCD price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. LUCD's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from LUCD; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against LUCD's historical range and other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
Lucid Diagnostics Inc. Common Stock's market cap is currently 196.48M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume826.56K
24h highest1.0300 USD
24h lowest0.96200 USD
24h Price movement-0.60%
Start trade with LUCD Perpetual
Sign up to trade